Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029)
Awarded
The competition has ended and a winner has been selected.
Farmasøytisk engroshandel
Sosiaali- ja terveysministeriö on tehnyt sopimuksen GlaxoSmithKline Oy:n kanssa yhdistelmärokotteiden toimittamisesta hepatiitti A:ta ja B:tä vastaan aikuisille ja lapsille/nuorille. Toimitukset tapahtuvat Helsinki-Uusimaalla, ja sopimuksen kesto on 2 vuotta (2025-2027) kahdella yhden vuoden optiolla (2027-2028, 2028-2029). Sopimuksen arvo on 798 288 euroa, ja se kattaa arviolta 12 000 annosta aikuisille ja 1 000 annosta lapsille/nuorille. Tarjouskilpailuun osallistui yksi toimittaja.
Result
- Winner
- GlaxoSmithKline Oy
- Number of bids
- 1
- Contract value
- €798,288
About the bid
- Contact name
- Hankintayksikkö
- Contact phone
- +358 295246000
- Contact email
- kilpailutus@thl.fi
- Address
- P.O. BOX 33, 00023 Helsinki
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis A and B combination Vaccine belonging to the National Vaccination Programme in Finland. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest reference price for the competition. The reference price will be calculated by adding the tendered prices for adult and children/adolescent doses together. The tenderer must offer a price for both adult and children´s vaccines. The contract period is two years 2025 - 2027. The procurement contains two one-year contract period renewals (1+1) to extend the contract for the periods 2027-2028 and 2028-2029. Estimated quantity for the contract period including contract period renewals is 12 000 doses for adults and 1000 doses for children/adolescents. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi ServiceMain features of the procedureAn open procedure is applied. The procurement will take place in compliance with the Directive 2014/24/EU on public procurement and the Finnish Act on Public Procurement and Concession Contracts (1397/2016). The estimated value of the procurement will exceed the EU threshold value. In case none of the tenders received meets the requirements of the Call for Tender as intended by the Customer, or if conditions change during the procurement process so that the Customer will be unable to make use of the results of the competitive bidding, the Customer may interrupt the procurement procedure. No compensation will be paid to the tenderers for preparing a tender, presenting it or other participations in the procedure. The Call for Tender documents are available in English.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Description
The reference price for the tender will be counted with the following formula (price per dose for the adult vaccine * 6000 doses) + (price per dose for the pediatric vaccine x 500 doses)=Reference price.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- Ministry of Social Affairs and Health
- Title
- Hepatitis A and B combination Vaccine for adults and children/adolescents 2025-2027 (2027-2028, 2028-2029)
- Type
- Main code
- Supplemental codes
- Location
- Helsinki-Uusimaa
- Duration
- 24 months